Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Climb Bio, Inc. (CLYM) had Earnings per Share (EPS) (Basic) of $-0.88 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-59.85M |
|
-- |
|
-- |
|
$67.88M |
|
$-67.88M |
|
$8.03M |
|
$-59.85M |
|
$-59.85M |
|
$-59.85M |
|
$-59.85M |
|
$-59.85M |
|
$-59.85M |
|
$-67.88M |
|
$-70.06M |
|
67.81M |
|
67.81M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.88 |
$-0.88 |
|
| Balance Sheet Financials | |
$105.85M |
|
$0.29M |
|
$61.90M |
|
$167.74M |
|
$6.98M |
|
-- |
|
$0.28M |
|
$7.27M |
|
$160.47M |
|
$160.47M |
|
$160.47M |
|
47.77M |
|
| Cash Flow Statement Financials | |
$-54.36M |
|
$2.83M |
|
$-0.02M |
|
$87.23M |
|
$35.69M |
|
$-51.54M |
|
$8.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-54.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.30% |
|
-37.30% |
|
-35.68% |
|
-37.30% |
|
$3.36 |
|
$-0.80 |
|
$-0.80 |
|